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The use of grading tools for the 
description of the severity of pressure 
ulcers has been described for several 
decades. However, since their first 
use, many authors have identified 
considerable shortcomings with them, 
which have not improved significantly 
despite an increasing number of 
systems being available.
There is no evidence that 
grading the severity of the damage 
has any significant impact on the 
management of pressure ulcers, 
for example, the grade gives no 
indication of the size, tissue type, 
presence or absence of infection or 
any other clinical indicator, therefore 
it serves no useful purpose in terms 
of planning care aimed at, where 
possible, healing the ulcer. Some areas 
and some guidelines, most noteably 
the National Institute of Health and 
Clinical Excellence (NICE, 2005) 
and the European Pressure Ulcer 
Advisory Panel/National Pressure 
Ulcer Advisory Panel (EPUAP/NPUAP, 
2009), offer guidance based on two 
groupings, categories 1 and 2 and 
categories 3 and 4, where different 
levels of equipment may be used. 
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However, they do not offer separate 
guidance for each category.
Why else may the category of 
damage be collected? Most trusts 
collect data on the severity of 
damage within both their prevalence 
and incidence data. However, in 
most other disease states this is not 
the case, both of these counting 
systems are about the occurrence 
of the disease, the patient either 
has, or does not have, a pressure 
ulcer, what additional information 
is gained from knowing the severity. 
The majority of documents, for 
example, the International Guidelines 
on Pressure Ulcer Prevalence and 
Incidence (MEP, 2009) or the Nurse 
Sensitive Outcome Indicators (CNO, 
2010) do not mention the severity of 
damage in the calculation. Some may 
argue that identifying the severity 
has considerable cost implications 
citing the cost models used within, 
for example, the Pressure Ulcer 
Productivity Calculator (Department 
of Health [DH], 2010), costings 
which are based on averages which 
are based on guesstimates, no one 
really knows the cost of managing a 
patient with a pressure ulcer — and 
surely the cost varies so considerably 
between cases it would be impossible 
to determine.
The only reliable evidence 
that exists about pressure ulcers 
is that clinicians are unable to 
correctly grade them (Defloor and 
Schoonhoven, 2004; Briggs, 2006; 
Beeckman et al, 2007), and are often 
unable to distinguish them from 
wounds of other aetiologies such as 
moisture lesions or incontinence-
associated dermatitis (Beeckman et 
al, 2008; McDonagh 2008).
Yet, over the last two years, there 
has been increasing pressure put 
on tissue viability nurses to collect, 
interpret and manipulate data based 
on the frequency and grades of 
pressure ulcers occurring within their 
trusts. In many (but by no means all) 
trusts, the occurrence of a category 3 
or 4 not only triggers an incident form 
but also a root cause analysis (this 
may take many and varied forms). 
CQUIN targets focus not only on 
reduction of occurrence of pressure 
ulcers, but reduction of particular 
grades. Is this all just a huge waste 
of time? Tissue viability nurses and 
university lecturers spend more man 
hours than is reasonable trying to 
educate clinicians to correctly identify 
these wounds — so far, with little 
success, so what is the point in basing 
quality metrics on what is clearly 
wildly inaccurate information? Can 
we judge the quality of care that is 
delivered when we have no reliable 
way to measure the outcome of 
interest?
Given these inaccuracies, would 
it not be better to have only three 
categories (and thus reduce the 
chance of inaccuracies purely by 
reducing choice), namely:
8 Non-blanching erythema (NBE), 
as the late and very pragmatic 
Tom Defloor said, this is a warning 
sign of impending damage, a 
point clearly illustrated in the 
randomised controlled trial (RCT) 
by Vanderwee et al (2007) who 
used NBE as a risk indicator 
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CJ: ...only a small percentage of clinicians can accurately assess what is and is not pressure damage.
. 
KO: ... students will often experience patients with skin damage early in their training and this may not have 
been covered in the curriculum. Thus, why have clinical staff not informed them about grading systems? 
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Do you believe clinicians accurately identify 
pressure ulcers as distinct from other 
aetiologies, particularly on the sacrum  
and heel?
 
KO:   No. I have had many a 
conversation/debate with clinical staff 
regarding the differences between 
moisture lesions and pressure ulcers, or 
if, in fact, there is a difference between 
the two. With respect to pressure ulcers 
on heels, this can cause controversy 
between professional groups. For 
example, if I discuss damage to the skin 
on a heel in a patient with diabetes, 
many nurses will state it is a pressure 
ulcer and the patient has diabetes. If I 
discuss the same skin damage with a 
podiatrist, they will say it is a diabetic 
Do you think clinicians can reliably 
distinguish between different categories of 
pressure damage? 
KO:   I do not believe that all clinicians 
are able to categorise accurately pressure 
damage, especially junior members 
of staff. Many tissue viability specialists 
and tissue viability consultant nurses 
are able to distinguish between the 
categories with some clarity, yet many 
say that it is subjective and, as a result, 
in many cases, they make an ‘informed 
decision’. Interestingly though, when I 
ask students which system they use to 
categorise pressure ulcers, the answer I 
often receive is Waterlow. When I discuss 
the EPUAP guidance on categorisation 
of pressure damage, the majority of 
students state that they have not heard 
of this, or will say, ‘oh yes, I have seen 
those pictures on cards in the clinical 
areas, but I didn’t know it had a name’. 
Who should be teaching the students 
about these systems? Arguably, academic 
staff should ensure that they know about 
national guidance and that the clinicians 
should be teaching them about local 
guidance and explaining how national 
and local guidance influences care 
delivery. However, students will often 
experience patients with skin damage 
early in their training and this may not 
have been covered in the curriculum. 
Thus, why have clinical staff not informed 
them about grading systems? Can we 
assume that some clinicians themselves 
do not understand the systems? 
MC:  There have been a number 
of publications reporting the reliability 
with which clinicians distinguish 
between the different categories of 
pressure damage (Beeckman et al, 
2007; Defloor et al, 2006; Kottner 
in a direct comparison against 
Braden. The patients who were 
risk assessed by NBE developed no 
more or no more severe pressure 
ulcers than those assessed using 
the Braden scale. However, the 
ward only used a third of the 
amount of equipment than the 
ward that used Braden — a huge 
cost-saving
8 Superficial damage, i.e. damage 
that only involves the skin, as 
long as appropriate care is 
implemented, seems to get better 
in a relatively straightforward way
8 Deep tissue damage: in addition to 
any ulcers that obviously progress 
through the dermis, this could 
include all those pressure ulcers 
counted as ‘unstageable, deep 
tissue injury, or evolving’ anywhere, 
where it is clear from the texture, 
temperature and colour of the 
skin that there is clearly deeper 
damage. JF
foot ulcer. Who is correct? More 
importantly, should they follow the 
guidance on treating a pressure ulcer or 
the guidance on management of diabetic 
foot ulcers? 
MC:  The prevalence and incidence 
of pressure ulcers will be influenced by 
clinicians’ ability to correctly identify early 
signs of pressure damage, as distinct 
from other changes in the skin at the 
anatomical locations where pressure 
ulcers commonly occur. One example 
of potential misdiagnosis can be seen 
in discussion of whether pressure or 
exposure to moisture (the so-called 
moisture lesion) caused the change 
in the appearance of the skin. Where 
pressure ulcer experts continue to 
discuss the accurate detection of early 
stages of pressure damage, it would 
appear logical that clinicians in everyday 
practice will face challenges in making 
differential diagnoses of the cause of 
skin changes. However, it would appear 
sensible to consider pressure and 
shear as probable contributors to early 
skin changes at body sites that usually 
support body weight, such as the sacrum 
and heel.
CJ:  In our experience of working 
with trusts across the UK, the biggest 
issue is that nurses who are asked to 
identify pressure ulcers, have little if any 
training, and are relatively unqualified 
when it comes to grading. There are 
often only one or two specialist TVNs in 
any hospital and this lack of education 
puts an additional strain on already 
overstretched resources.  
Only a small percentage of clinicians 
can accurately assess what is and is not 
pressure damage.
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MC:  The management of all pressure 
ulcers must take as its foundation the 
requirement to reduce or remove 
high mechanical loads being applied 
to vulnerable skin and soft tissue. As 
the vulnerability of the skin increases, 
or where severe pressure ulcers are 
present, it would appear sensible to use 
interventions that exert greater control 
over the duration or magnitude of 
tissue loading. This would suggest that 
the interventions used in pressure ulcer 
prevention and healing would change 
as risk increased, or where pressure 
ulcers are more severe, as reflected in 
the recent EPUAP/NPUAP pressure 
ulcer guidelines (EPUAP/NPUAP, 
2009). However, clinical guidelines have 
not seen fit to discuss management 
strategies by individual category of 
pressure ulcer, with a distinction only 
being made between the management 
steps taken where partial or full-
thickness pressure ulcers  
are encountered.
CJ:  Absolutely, but again, by less 
trained and experienced staff. The higher 
the category, the higher the priority it 
receives in terms of clinical management.  
However, at Your Turn, we believe that it 
is as important to identify those that are 
at a high risk of developing category 1 
pressure ulcers and having an appropriate 
strategy for this, as it is to identify a 
category 4 pressure ulcer. Clinical 
management has to be about the overall 
wellbeing of the patient and preventing 
pressure ulcers, or stopping the 
progression of an existing ulcer should be 
part of this plan.  
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